PL3900704T3 - Kopolimer blokowy zawierający hydrofilowy pierwszy blok, hydrofobowy drugi blok i grupę funkcyjną zdolną do specyficznego wiązania z tiolem - Google Patents

Kopolimer blokowy zawierający hydrofilowy pierwszy blok, hydrofobowy drugi blok i grupę funkcyjną zdolną do specyficznego wiązania z tiolem

Info

Publication number
PL3900704T3
PL3900704T3 PL19900252.8T PL19900252T PL3900704T3 PL 3900704 T3 PL3900704 T3 PL 3900704T3 PL 19900252 T PL19900252 T PL 19900252T PL 3900704 T3 PL3900704 T3 PL 3900704T3
Authority
PL
Poland
Prior art keywords
block
thiol
hydrophilic
hydrophobic
functional group
Prior art date
Application number
PL19900252.8T
Other languages
English (en)
Inventor
Won Jong Kim
Dong Hyun Jang
Original Assignee
Gi Cell, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gi Cell, Inc. filed Critical Gi Cell, Inc.
Publication of PL3900704T3 publication Critical patent/PL3900704T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4613—Natural-killer cells [NK or NK-T]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/321—Polymers modified by chemical after-treatment with inorganic compounds
    • C08G65/325—Polymers modified by chemical after-treatment with inorganic compounds containing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C08G65/331—Polymers modified by chemical after-treatment with organic compounds containing oxygen
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G81/00—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G81/00—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers
    • C08G81/02—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers at least one of the polymers being obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • C08G81/024—Block or graft polymers containing sequences of polymers of C08C or C08F and of polymers of C08G
    • C08G81/025—Block or graft polymers containing sequences of polymers of C08C or C08F and of polymers of C08G containing polyether sequences
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the cancer treated
    • A61K2239/55—Lung
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2/00—Addition polymers of aldehydes or cyclic oligomers thereof or of ketones; Addition copolymers thereof with less than 50 molar percent of other substances
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL19900252.8T 2018-12-17 2019-12-17 Kopolimer blokowy zawierający hydrofilowy pierwszy blok, hydrofobowy drugi blok i grupę funkcyjną zdolną do specyficznego wiązania z tiolem PL3900704T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20180163379 2018-12-17
PCT/KR2019/017899 WO2020130580A1 (ko) 2018-12-17 2019-12-17 친수성 제1 블록, 소수성 제2 블록, 및 티올과 특이적으로 결합할 수 있는 작용기를 포함하는 블록 공중합체

Publications (1)

Publication Number Publication Date
PL3900704T3 true PL3900704T3 (pl) 2024-03-18

Family

ID=71102199

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19900252.8T PL3900704T3 (pl) 2018-12-17 2019-12-17 Kopolimer blokowy zawierający hydrofilowy pierwszy blok, hydrofobowy drugi blok i grupę funkcyjną zdolną do specyficznego wiązania z tiolem

Country Status (18)

Country Link
US (1) US20210346308A1 (pl)
EP (1) EP3900704B1 (pl)
JP (2) JP7265000B2 (pl)
KR (1) KR102354882B1 (pl)
CN (2) CN117159491A (pl)
AU (1) AU2019407590B2 (pl)
CA (2) CA3206647A1 (pl)
DK (1) DK3900704T3 (pl)
ES (1) ES2966163T3 (pl)
FI (1) FI3900704T3 (pl)
HR (1) HRP20231550T1 (pl)
HU (1) HUE065015T2 (pl)
PL (1) PL3900704T3 (pl)
PT (1) PT3900704T (pl)
RS (1) RS64992B1 (pl)
SI (1) SI3900704T1 (pl)
TW (1) TWI726540B (pl)
WO (1) WO2020130580A1 (pl)

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU726749B2 (en) * 1995-08-10 2000-11-16 Kazunori Kataoka Block polymer having functional groups on its both ends
KR100574341B1 (ko) * 2003-11-18 2006-04-26 학교법인 성균관대학 썰폰아마이드 이용 ｐＨ 민감성 블록공중합체의 제조 방법및 그에 의한 블록공중합체와 마이셀
KR100732013B1 (ko) * 2005-03-18 2007-06-25 성균관대학교산학협력단 ｐＨ 민감성 블록 공중합체 및 이를 이용한 고분자 마이셀
KR100665672B1 (ko) * 2005-04-13 2007-01-09 성균관대학교산학협력단 새로운 온도 및 ｐＨ 민감성 블록 공중합체 및 이를 이용한고분자 하이드로겔
JP2009534309A (ja) * 2006-03-31 2009-09-24 マサチューセッツ インスティテュート オブ テクノロジー 治療剤の標的化送達のためのシステム
WO2008124639A2 (en) * 2007-04-04 2008-10-16 Massachusetts Institute Of Technology Poly (amino acid) targeting moieties
KR20080095130A (ko) * 2007-04-23 2008-10-28 한국과학기술연구원 ｐＨ 민감성 블록공중합체를 이용한 약물전달체 제조 및응용
KR100838809B1 (ko) 2007-05-03 2008-06-17 성균관대학교산학협력단 겔강도가 우수한 온도 및 피에치 민감성 블록 공중합체 및이의 제조방법과 이를 이용한 약물전달체
KR100941774B1 (ko) * 2007-09-06 2010-02-11 성균관대학교산학협력단 인체안전성이 우수한 온도 및 피에치 민감성 블록공중합체및 이의 제조방법과 이를 이용한 약물전달체
KR101586866B1 (ko) * 2010-04-14 2016-01-21 가톨릭대학교 산학협력단 약물 전달을 위한 ｐＨ-민감성 나노입자 및 이의 제조방법
WO2012040513A1 (en) * 2010-09-22 2012-03-29 The Board Of Regents Of The University Of Texas System Compositions and methods for the delivery of beta lapachone
KR101386176B1 (ko) * 2010-11-12 2014-04-18 성균관대학교산학협력단 피에이치 민감성 폴리머좀 및 이의 제조방법
US9511152B2 (en) * 2012-04-05 2016-12-06 The Board Of Regents Of The University Of Texas System Multicolored pH-activatable fluorescence nanoplatform
CN103316354A (zh) * 2013-05-27 2013-09-25 上海纳米技术及应用国家工程研究中心有限公司 肿瘤靶向多肽-聚乙二醇-聚乳酸复合物及制备方法和应用
KR101554703B1 (ko) * 2014-02-21 2015-09-23 전북대학교산학협력단 벤조일옥시신남알데히드-폴리에틸렌글리콜 결합 마이셀에 아연 프로토포르피린을 담지한 pH 감응형 항암 전구약물 및 이의 제조방법
AU2016295602B2 (en) * 2015-07-22 2019-11-14 Gnt Biotech & Medicals Corporation PH-sensitive linkers for delivering a therapeutic agent
KR102023058B1 (ko) * 2016-03-25 2019-09-19 사회복지법인 삼성생명공익재단 이중 이온 pH-민감성 공중합체를 이용한 허혈성 뇌질환 치료용 약물 전달체
EP3530291A1 (en) * 2018-02-27 2019-08-28 Universite De Geneve Bi-functionalizable amphiphilic diblock copolymers, conjugates and uses thereof

Also Published As

Publication number Publication date
EP3900704A1 (en) 2021-10-27
JP7265000B2 (ja) 2023-04-25
HUE065015T2 (hu) 2024-04-28
CA3112314A1 (en) 2020-06-25
KR102354882B1 (ko) 2022-01-25
CN112955127B (zh) 2024-02-27
CN117159491A (zh) 2023-12-05
RS64992B1 (sr) 2024-01-31
AU2019407590A1 (en) 2021-04-08
TW202039003A (zh) 2020-11-01
TWI726540B (zh) 2021-05-01
EP3900704B1 (en) 2023-11-01
US20210346308A1 (en) 2021-11-11
HRP20231550T1 (hr) 2024-05-10
FI3900704T3 (fi) 2023-11-30
JP2023109749A (ja) 2023-08-08
WO2020130580A1 (ko) 2020-06-25
PT3900704T (pt) 2023-11-27
CA3112314C (en) 2023-09-19
EP3900704A4 (en) 2022-02-09
ES2966163T3 (es) 2024-04-18
AU2019407590B2 (en) 2022-08-04
KR20200074899A (ko) 2020-06-25
DK3900704T3 (da) 2023-12-04
SI3900704T1 (sl) 2024-01-31
JP2022510765A (ja) 2022-01-28
CN112955127A (zh) 2021-06-11
CA3206647A1 (en) 2020-06-25

Similar Documents

Publication Publication Date Title
EP3817822A4 (en) PROTEIN DEGRADANTS AND USES THEREOF
EP3737666A4 (en) PROTEIN DEGRADANTS AND USES THEREOF
EP3684365A4 (en) PROTEIN DEGRADATION AGENTS AND USES OF SUCH
EP3676244A4 (en) MOLECULES PRESENTING ONE HYDROPHOBIC GROUP AND TWO IDENTICAL HYDROPHILIC IONIC GROUPS AND CORRESPONDING COMPOSITIONS
EP3652212A4 (en) LAG-3 BINDING ANTIBODIES AND USES THEREOF
EP3505543A4 (en) HYDROPHILIC COPOLYMER AND MEDICAL DEVICE
EP3702380A4 (en) Olefin-olefinic alcohol copolymer, and preparation method therefor
EP3886870A4 (en) CELL MEMBRANE NANOPARTICLES AND USES THEREOF
AU2018290633A1 (en) Conjugate of VEGF-Grab protein and drug, and use thereof
EP3786944A4 (en) COMPOSITION FOR SOUND-INSULATING PANEL, SOUND-INSULATING PANEL AND SOUND-INSULATING STRUCTURAL BODY
EP3719044A4 (en) CYCLIC OLEFIN-BASED COPOLYMER, CYCLIC OLEFIN-BASED COPOLYMER COMPOSITION, MOLDED BODY AND MEDICAL CONTAINER
EP3862024A4 (en) SHORT INTERFERENT RNA CONJUGATE, METHOD FOR PREPARATION AND USE THEREOF
EP3700542A4 (en) RECOMBINANT IMMUNE CELLS, METHOD OF MANUFACTURING AND METHOD OF USE
EP3418319A4 (en) SILOXANE MONOMER, COMPOSITION FOR PREPARING A SILICONE HYDROGEL LENS CONTAINING SAME, AND SILICONE HYDROGEL LENS
EP3589670A4 (en) ELASTOMER, ITS PREPARATION PROCESS AND ASSOCIATED USE
EP3299401A4 (en) Acrylic block copolymer, resin composition and molded body comprising same, and optical member
EP3431517A4 (en) Copolymer and surface treatment
EP3705121A4 (en) EMOPAMIL BINDING PROTEIN BINDING AGENT AND ITS USE
EP3932948A4 (en) ANTIBODY BINDING TO HUMAN LAG-3 AND METHOD OF MANUFACTURE AND USE THEREOF
EP3511351A4 (en) COPOLYMER AND MANUFACTURING METHOD THEREFOR
EP3263107A4 (en) Block copolymer conjugate of physiologically active substance
EP3882284A4 (en) ACRYLAMIDE COPOLYMER AND PROCESSES FOR PRODUCTION THEREOF AND USE THEREOF
EP3536723A4 (en) COPOLYMER RUBBER AND METHOD FOR THE PRODUCTION THEREOF AND CROSSLINKED RUBBER COMPOSITION
EP3845599A4 (en) COMPOSITION AND ELASTIC BODY
IL285368A (en) Protein-based hydrogel